Chemotherapy   

Questions discussed in this category


Are there other measures, pharmocologic or adjunctive, that can be used or are under investigation to mitigate cardiotoxicity related to chemo- or rad...

Please specify how your institution is allocating resources now or will be soon.

For patients not on study, would you consider replacing missed doses of peg with a non-asparaginase based chemotherapy?

Are there contraindications to drugs like oxaliplatin or abraxane? Does chronicity or severity of the patient's underlying symptoms play a role in yo...


Papers discussed in this category


BJR Case Rep, 2018 Sep 08

Cancers (Basel), 2022 Apr 14

The Lancet. Oncology, 2017-09

J Clin Oncol, 2020 Apr 10

Journal of the National Cancer Institute, 2016-06

Pediatrics, 2014 Feb 02

N. Engl. J. Med.,

The Journal of urology, 2018-12

N. Engl. J. Med.,

Lancet Oncol., 2014 Feb 18

NEJM Evidence, 2022 Jun 1

Br J Cancer, 2014 Apr 15

Cancer, 2011-06-15

Eur J Cancer, 2017 Nov 28

N. Engl. J. Med., 2019 Sep 28

Lancet Oncol, 2021 Jan 18

J Clin Oncol, 2021 Apr 19

J Clin Oncol, 2003 Jul 01

Mediterranean journal of rheumatology, 2022 Mar 31

Pediatric blood & cancer, 2015-06

Leukemia & lymphoma, 2018-08

Haematologica, 2016 Mar

Eur Heart J, 2022 Nov 01

JACC. Heart failure, 2022 Jun 08

JAMA, 2023 Aug 8

Cardio-oncology (London, England), 2021 Sep 27

JACC. CardioOncology, 2023 Jun 20